Burns Matteson Capital Management, LLC Organon & Co. Transaction History

Burns Matteson Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$10.95 - $17.32 $317,418 - $502,072	-28,988 Closed	0 $0
Q3 2023 Jan 12, 2024	BUY	$16.59 - $23.77 $480,910 - $689,044	28,988 New	28,988 $503 Million
Q2 2023 Dec 11, 2023	SELL	$19.27 - $24.63 $457,065 - $584,198	-23,719 Closed	0 $0
Q1 2023 Dec 11, 2023	SELL	$21.42 - $32.08 $11,374 - $17,034	-531 Reduced 2.19%	23,719 $558 Million
Q4 2022 Dec 11, 2023	BUY	$23.31 - $28.61 $565,267 - $693,792	24,250 New	24,250 $677 Million
Q3 2022 Dec 11, 2023	SELL	$23.4 - $34.25 $507,101 - $742,231	-21,671 Closed	0 $0
Q2 2022 Dec 11, 2023	BUY	$31.66 - $38.9 $686,103 - $843,001	21,671 New	21,671 $731 Million

795

191M

1.59M

931K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.73B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.